Uncle Sam Auctions Off Cool Inventions to Eager Companies
Published Date: 7/2/2025
Notice
Summary
The U.S. Government owns a cool new invention that's ready for companies to license and turn into real products fast. This opportunity is open to businesses interested in bringing federally funded research to life, with some inventions even protected internationally to boost market reach. Act now to grab a license and start making money from these smart ideas!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Government Invention Available to License
If you are a business interested in commercializing federally funded research, the U.S. Government owns an invention that is available for licensing so companies can bring the technology to market quickly. The notice says the invention is owned by a U.S. Government agency and is being offered to achieve expeditious commercialization of federally funded R&D.
Foreign Patents Extend Licensing Reach
Foreign patent applications have been filed for selected inventions to extend market coverage, and those internationally protected inventions may also be available for licensing. This can help licensees pursue markets outside the United States for selected government-owned technologies.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2025-12390 — New Postal Products
The Postal Service just filed a new deal for special mail services, and the Commission is checking it out. This affects businesses and customers who use these special mail options, with possible changes coming soon. The public can share their thoughts before any final decisions are made.
Next: 2025-12392 — Agency Information Collection Activities: Comment Request; National Science Foundation Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Pre-Award Information Collection.
The National Science Foundation (NSF) wants to keep collecting info from small businesses applying for their SBIR/STTR programs. They’re asking the public to share thoughts before they get official approval to continue for up to 3 more years. This affects small businesses aiming for innovation funding and helps NSF keep things running smoothly without extra costs or delays.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in